Clinical trials explained: Why imagery matters…
January 29, 2024 | Branding, Imagery, clinical trial recruitment, clinical trials, design, recruitment
Recruiting patients for clinical trials is one of pharma’s greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the decision to join a trial.
As humans we can process images much faster than words. Which is why choosing the correct imagery is incredibly important when developing materials for patients. On the one hand, images can help add meaning to a story but when used incorrectly, can confuse the reader.
Images can also evoke strong emotions. So careful placement of imagery can help to replace negative emotions such as fear and anxiety, with more positive ones instead, specifically reassurance.
Fears and concerns about taking part, alongside a lack of information and awareness are some of the major hurdles for clinical trial recruitment. Deciding to join one or not is a highly emotive decision for potential participants, so being able to connect with them on an emotional level is vital to help put them at ease and allow them to think clearly about the decision at hand.
Connecting on an emotional level is what really counts and using imagery is a great way to do that.
Grabbing attention
To build trial awareness, recruitment advertising is crucial. Making clinical trials visible in the community, such as in pharmacies and doctors’ surgeries, is a great way to communicate directly with people who might otherwise be unaware that recruitment is taking place.
As well as being visible in the right places, recruitment adverts also need to stand out from the crowd and ultimately ‘speak’ to people. Here’s what we think recruitment advertising should do…
We all lead busy lives and are constantly bombarded with information from lots of different places. So, to attract the reader’s attention we must first catch their eye with something that stands out. That’s the hard bit done! Then it’s a case of keeping that attention by stimulating interest, before establishing a connection with the reader, compelling them to act.
Recruitment advertising, done well, can do all three!
So, how do we make sure it’s done well?
For us, it begins by gathering insights through focus groups, interviews, and social listening which allows us to gather important patient insights. These help us to not only understand possible emotional responses, but also what information people considering joining a clinical trial want to know. A branding model can also help establish what motivates people to participate in a trial.
With this information, we can then start to think about how we use these insights to develop meaningful, yet eye-catching imagery for our recruitment adverts.
Of course, we also challenge the imagery at every step by asking some very key questions. Things such as:
- How can we make this stand out on a busy clinic noticeboard?
- Will it resonate with patients and their families?
- Could it spark people’s curiosity to learn more about the study?
- Can the imagery and graphic style be used across all study materials to help create continuity and a feeling of recognition and trust?
- Could the use of icons enhance and support the story or content? Iconography is great at conveying information and elevating information – you can read more about iconography here.
Pictures can often live up to their promise of speaking a thousand words. And often in the context of clinical trials, they can be the unspoken words that help to build an emotional connection. Which is exactly why we prioritise understanding patients’ perspectives and creating meaningful imagery when supporting clients with their clinical trial materials.
If you’d like to get a picture of how we could help with your clinical trials, let’s talk.
You can read all our latest clinical trials explained blogs here.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Invited, but not equipped: patient involvement needs more than an open door
Explore how pharma can help patients and patient organisations prepare for meaningful involvement in EU HTA without shaping their contribution.
The outcomes are already chosen. So when can patients really shape them?
Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in clinical trials.
Long-term clinical trial engagement is a behavioural challenge – not just an informational one
Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can help participants stay connected, confident and committed throughout a study.
Patients are telling the truth — just not to you
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
When what matters to patients is hard to measure
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical endpoints measure.
Permission to pause: making treatment breaks part of the cancer care conversation
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
A seat at the table: what the EU HTA reforms really ask of patient involvement
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
Why faster trials make participant understanding more important than ever
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.